Updates in Germline Clinical Testing for Breast Cancer

Video

This video reviews studies investigating the use of germline clinical testing for breast cancer.

In this video, Julie Nangia, MD, of Baylor College of Medicine in Houston, highlights abstracts investigating the use of germline clinical testing for breast cancer, including a study on general population testing and more.

Nangia was a discussant for a spotlight session on this topic at the 2017 San Antonio Breast Cancer Symposium (SABCS), held December 5–9 in San Antonio, Texas.

Recent Videos
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.
Pegulicianine-guided breast cancer surgery may allow practices to de-escalate subsequent radiotherapy, says Barbara Smith, MD, PhD.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Carey Anders, MD, an expert on breast cancer
Related Content
Treatment with RLY-2608 plus fulvestrant appears well tolerated among patients with PI3Kα-mutated breast cancer in the ReDiscover trial.

Novel PI3Kα Inhibitor Combo Shows Meaningful PFS in HR+/HER2– Breast Cancer

Russ Conroy
September 10th 2024
Article

Treatment with RLY-2608 plus fulvestrant appears well tolerated among patients with PI3Kα-mutated breast cancer in the ReDiscover trial.

Neil M. Iyengar, MD, and Paolo Tarantino, MD, discuss updated data on agents such as T-DXd and abemaciclib in breast cancer presented at 2024 ASCO.

Applying Updated Breast Cancer Findings From ASCO to Clinical Practice

Neil M. Iyengar, MD;Paolo Tarantino, MD
June 17th 2024
Podcast

Neil M. Iyengar, MD, and Paolo Tarantino, MD, discuss updated data on agents such as T-DXd and abemaciclib in breast cancer presented at 2024 ASCO.

2 Is Laterality in Breast Cancer Still Worth Studying? Local Experience in Bahrain

2 Is Laterality in Breast Cancer Still Worth Studying? Local Experience in Bahrain

Suhair Al Saad;Hamdi Al Shenawil;Amer Almarabheh;Noor Al Shenawi;Abdulla Ismaeel Mohamed;Rami Yaghan
August 30th 2024
Article
Neil M. Iyengar, MD, spoke about the potential impact of exercise on patient-reported outcomes in cancer and achieving work-life balance.

Finding a Place for Exercise Oncology in the Treatment of Breast Cancer

Neil M. Iyengar, MD
May 20th 2024
Podcast

Neil M. Iyengar, MD, spoke about the potential impact of exercise on patient-reported outcomes in cancer and achieving work-life balance.

3 Gender Disparities in the National Institutes of Health Funding for Breast Cancer

3 Gender Disparities in the National Institutes of Health Funding for Breast Cancer

Muhammad Zain Farooq;Aruba Sohail;Sara Khan;Ibrahim Zahid;Shaival Thakore;Janta Ukrani;Michael Vishal Jaglal
August 30th 2024
Article
4 Bacopaside: Exploring Its Potential in Addressing Chemoresistance and Modulating Doxorubicin Accumulation in Triple-Negative Breast Cancer Cells

4 Bacopaside: Exploring Its Potential in Addressing Chemoresistance and Modulating Doxorubicin Accumulation in Triple-Negative Breast Cancer Cells

Sima K. Rad;Kenny K. L. Yeo;Runhao Li;Saifei Liu;Fangmeinuo Wu;Kevin A. Fenix;Timothy J. Price;Wendy Ingman;Amanda R. Townsend;Eric Smith
August 29th 2024
Article